Cargando…

SAT-LB126 Metformin Attenuates Sodium Retention and Blood Pressure in Hypertensive Diabetic Mice by Reducing the Phosphorylation of Renal NCC and Its Association With the Actin Cytoskeleton

Metformin is the first-line drug in the treatment of type 2 diabetes mellitus. The aim of this work was to evaluate the efficacy of metformin treatment in reducing blood pressure and investigate the molecular mechanism using a preclinical animal model. Adult male and female diabetic db/db mice with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gholam, Mohammed F, Waleed, Alina, Tuna, Kubra M, Carson-Marino, Morgan, Chacko, Kevin M, Malik, Zeeshan S, Schramm, Whitney C, Lopez, Juliana V Pena, Alli, Abdel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209095/ http://dx.doi.org/10.1210/jendso/bvaa046.2201

Ejemplares similares

SAT-LB127 Regulation of ENaC by Exosomal Lipids in the Diabetic Kidney
por: Tuna, Kubra M, et al.
Publicado: (2020)

SAT-LB128 A Case of Metformin Associated Lactic Acidosis and the Importance of Medication Reconciliation in End-Stage Renal Disease
por: Tsai, Karen, et al.
Publicado: (2020)

SAT-LB030 Efficacy of Combined Therapy with Metformin and Sitagliptin in Patients with Type 2 Diabetes Who Did Not Reach Target Levels of Glycated Hemoglobin on Metformin Monotherapy
por: Klitsunova, Yuliia, et al.
Publicado: (2019)

SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020)

SAT-LB027 Does Diabetes Education Influence Glycosylated Hemoglobin?
por: Bhargava, Pooja, et al.
Publicado: (2019)

SAT-LB118 Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Arao, Kevin A, et al.
Publicado: (2020)

SAT-LB124 Phosphatidylcholine Transfer Protein Interacts With PPARδ to Modulate Activity
por: Druzak, Samuel Adam, et al.
Publicado: (2020)

SAT-LB117 POEMS Syndrome: Rare Presentation of New Onset Diabetes Mellitus
por: Jamal, Issra
Publicado: (2020)

SAT-LB115 Metformin-Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes Mellitus: The Sydney Memory and Ageing Study
por: Samaras, Katherine, et al.
Publicado: (2020)

SAT-LB029 Patient Participation Is Determined by Referral Source in an Intensive Diabetes Management Program
por: Blase, Bryan, et al.
Publicado: (2019)

SAT-LB024 Imprecision in Biomarker Analysis: Major Hurdle to Detection and Reversal of Disorders of Aging?
por: Comite, Florence, et al.
Publicado: (2019)

SAT-LB116 Extreme Insulin Resistance: The Diagnostic Challenges When Cost Is a Limitation
por: Cavalcante Parr, Nadia Carenina Nunes, et al.
Publicado: (2020)

SAT-LB033 Cryptolepine Action on Insulin Resistance in High-Glucose Diet-Fed Caenorhabditis Elegans
por: Young, Ryan, et al.
Publicado: (2019)

SAT-LB119 Diabetic Ketoacidosis With PUMP Failure: Analysis of the 2006-2016 U.S. Kid Inpatient Database
por: Everett, Estelle, et al.
Publicado: (2020)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

SAT-LB111 Improving Classification of Diabetes Etiology in Electronic Resources Using Phenotype Algorithms and Polygenic Risk Scores
por: Sulieman, Lina, et al.
Publicado: (2020)

SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
por: MS, ANEESH
Publicado: (2019)

MON-LB126 A Benign and Favorable Diagnosis: Glycogen Hepatopathy Causing Transient Transaminitis During Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
por: Yau, Alice, et al.
Publicado: (2020)

SAT-LB120 A Software Application Delivering Behavioral Therapy Improved Glycemic Control in Adults With Type 2 Diabetes
por: Guthrie, Nicole L, et al.
Publicado: (2020)

SAT-LB114 Metabolic Profile Changes in Patients With Diabetes Mellitus After Hurricane Maria: A Retrospective Case Series
por: Burgos, Nydia, et al.
Publicado: (2020)

SAT-148 Vitamin B12 Deficiency Among Patients with Metformin and Diabetic Neuropathy.
por: Alvarez, Mauricio, et al.
Publicado: (2019)

SAT-LB109 Implementation of a Quality Improvement Initiative for Advanced Ketone Management in Children With Recently Diagnosed Type 1 Diabetes
por: Jindal, Ishita, et al.
Publicado: (2020)

SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan
por: Hassanein, Mohamed, et al.
Publicado: (2020)

SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients
por: Malkhasyan, Victoria, et al.
Publicado: (2019)

SAT-LB122 Characterization and Functional Rescue of a Nephrogenic Diabetes Insipidus Causing S127F Substitution in V2 Vasopressin Receptor
por: Hunyady, Laszlo
Publicado: (2020)

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

SAT-LB032 Young Adult LEW.1WR1 Rats Develop Increased Glucose Intolerance on a Moderately Increased Sucrose Diet
por: Collins, Genoah, et al.
Publicado: (2019)

SAT-LB112 An Unusual Case of Ipilimumab/Nivolumab Induced Fulminant Diabetic Ketoacidosis (DKA) in a Non Diabetic Patient - a Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2020)

SAT-LB035 The G Protein-Coupled Estrogen Receptor GPER Plays a Dominant Role in Human Islet Cell Proliferation upon High Glucose
por: Shaklai, Sigal, et al.
Publicado: (2019)

SAT-LB125 Broad Spectrum Effects of a Ketogenic Diet Delivered by Remote Continuous Care on Inflammation and Immune Modulators in Type 2 Diabetes and Prediabetes
por: Phinney, Stephen, et al.
Publicado: (2020)

SAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m(2) in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes
por: Mathieu, Chantal, et al.
Publicado: (2019)

SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial
por: Rosenstock, Julio, et al.
Publicado: (2019)

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial
por: Snaith, Jennifer R, et al.
Publicado: (2020)

SAT-LB121 Development of a Machine-Learning Method for Predicting New Onset of Diabetes Mellitus: A Retrospective Analysis of 509,153 Annual Specific Health Checkup Records
por: Nomura, Akihiro, et al.
Publicado: (2020)

SAT-LB036 Late Weaning Leads to Enrichment of Treg Cells Which Consequently Regulates Effector T Cell Responses in Peri-Pancreatic Lymph Nodes and Pancreas of Humanized Model T1D
por: Imam, Shahnawaz, et al.
Publicado: (2019)

SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes
por: Singh, Harsimran, et al.
Publicado: (2020)

MON-126 Fulminant Type 1 Diabetes Caused by "Jumping"
por: Chen, Yaning, et al.
Publicado: (2019)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

MON-LB122 Psychiatric Medication Induced Diabetes Mellitus
por: Khanal, Bishal, et al.
Publicado: (2020)

SAT-660 Rare Case of Portal Vein Thrombosis Secondary to Acute Pyelonephritis in Type 1 Diabetic Patient
por: Alanazi, Alanoud, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fa4t5es3i4ceqpm65inuvcftmi